Page last updated: 2024-08-24

lamivudine and Hypertension, Portal

lamivudine has been researched along with Hypertension, Portal in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (66.67)29.6817
2010's1 (33.33)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Braude, J; Galambos, MR; Joelson, D; Johnson, M; Rubin, RA; Saifee, S; Sellers, M; Shrestha, R1
Archimandritis, A; Avgerinos, A; Burroughs, AK; Karamanolis, D; Kougioumtzan, A; Manolakopoulos, S; Papatheodoridis, G; Raptis, S; Theodoropoulos, J; Triantos, C; Tzourmakliotis, D; Vlachogiannakos, J1
Chang, HM; Chen, YS; Lee, SS; Tsai, HC; Wann, SR1

Reviews

1 review(s) available for lamivudine and Hypertension, Portal

ArticleYear
Noncirrhotic portal hypertension associated with didanosine: a case report and literature review.
    Japanese journal of infectious diseases, 2012, Volume: 65, Issue:1

    Topics: Aged, 80 and over; Antiretroviral Therapy, Highly Active; Ascites; Chemical and Drug Induced Liver Injury; Didanosine; Fatal Outcome; HIV Infections; HIV-1; Humans; Hypertension, Portal; Lamivudine; Male; Nevirapine; Portal Vein; Thrombosis; Tomography, X-Ray Computed

2012

Other Studies

2 other study(ies) available for lamivudine and Hypertension, Portal

ArticleYear
Noncirrhotic portal hypertension in patients with human immunodeficiency virus-1 infection.
    Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association, 2008, Volume: 6, Issue:10

    Topics: Adult; Anti-HIV Agents; CD4 Lymphocyte Count; Didanosine; Female; HIV Infections; HIV-1; Humans; Hypertension, Portal; Lamivudine; Male; Middle Aged; Risk Factors; Thrombophilia; Viral Load; Zidovudine

2008
Antiviral therapy reduces portal pressure in patients with cirrhosis due to HBeAg-negative chronic hepatitis B and significant portal hypertension.
    Journal of hepatology, 2009, Volume: 51, Issue:3

    Topics: Administration, Oral; Adult; Aged; Alanine Transaminase; alpha-Fetoproteins; Antiviral Agents; Biomarkers; DNA, Viral; Female; Follow-Up Studies; Hepatitis B e Antigens; Hepatitis B, Chronic; Humans; Hypertension, Portal; Lamivudine; Liver; Liver Cirrhosis; Male; Middle Aged; Portal Pressure; Prognosis; Prospective Studies; Treatment Outcome

2009